Amniotic fluid embolism (AFE) is a rare leading cause of unpredictable maternal death
in industrialized countries [
[1]
]. We present the management and sudden hemodynamic collapse of a patient due to a
suspected AFE complicated by an undiagnosed patent foramen ovale (PFO).To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Obstetrics and Gynecology and Reproductive BiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Risk factors, management, and outcomes of amniotic fluid embolism: A multicountry, population-based cohort and nested case-control study.PLoS Med. 2019; 16: e1002962
- Anesthesia for Obstetric Disasters.Anesthesiol Clin. 2020; 38: 85-105
- Amniotic Fluid Embolism Treated with Veno-Arterial Extracorporeal Membrane Oxygenation.Case Rep Crit Care. 2019; 2019: 1-4
- University of Alberta Hospital Cardiac Arrest T. Successful inter-hospital transfer for extracorporeal membrane oxygenation after an amniotic fluid embolism induced cardiac arrest.Can J Anaesth. 2016; 63: 507-508
- The Role of Extra Corporeal Membrane Oxygenation in Amniotic Fluid Embolism: A Case Report and Literature Review.Cureus. 2021; 13e13566
Article info
Publication history
Published online: August 08, 2021
Accepted:
August 3,
2021
Received:
June 18,
2021
Identification
Copyright
© 2021 Elsevier B.V. All rights reserved.
